He is also serves as consultant at Zohdan Bio, where he provides strategic support for preclinical R&D programs focused on gene therapy, genome editing, and virology. With a deep foundation in oncology and biologics, Dr. Usmani has led groundbreaking work in both academia and industry, including his tenures at Sana Biotechnology, Harvard Medical School and Massachusetts General Hospital. He's led and spearheaded the development of innovative in vivo genome editing platforms, optimized viral vectors, and engineered cutting-edge reporter assays.
Shariq Usmani, PhD
Massachusetts General Hospital, Harvard Medical School
Research Expertise
About
Legacy Map
Full ViewPublications
Education
University of Konstanz
PhD, Molecular and Cell Biology / May, 2011
Harvard University
Postdoctoral fellow, Virology/Immunology / 2019
Experience
Cabaletta Bio
Scientific Director / 2024 — Present
I lead a research team in the preclinical R&D organization at Cabaletta bio. I directly manage a talented group of Senior Scientists, Scientists and Research Associates to spearhead and drive innovation in cell therapies and biologics in autoimmune disease indications.
Sana Biotechnology
Principal Scientist / 2022 — 2023
As a team lead, I led efforts to establish in vivo genome editing platform, vector design/engineering and optimization, with a broader goal to develop innovative and effective genomic medicine for unmet medical needs.
Zohdan Bio
Consultant / 2024 — Present
Providing strategic support for all aspects of preclinical, R&D programs in gene therapy, genome editing and virology and immunology space.
Massachusetts General Hospital
Senior Staff Scientist / 2019 — 2022
Principal Investigator on an NIH funded grant award to study virus-immune interaction and immune evasion mechanisms. I directed all project aspects including planning, writing, finance/budgeting, and supervision and mentoring of direct reports. Developed a novel multiphoton intravital imaging platform to study virus-immune cell interactions in vivo in lymphoid and mucosal tissues during acute stages of HIV infection.
Join Shariq on NotedSource!
Join Now
At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.
For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.
For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.
Expert Institutions
Proudly trusted by
